FEETEG and LAL-D Patient Oganization – Together for Research

FEETEG and LAL-D Patient Oganization – Together for Research

5 Sep, 2026 | blog

FEETEG and LAL-D Patient Organization Renew Their Collaboration Agreement On September 3, 2026, the Spanish Foundation for the Study and Treatment of Gaucher Disease and other Lysosomal Disorders (FEETEG) and LAL-D Patient Organization officially renewed their...
“Lipids and Health” Conference

“Lipids and Health” Conference

6 Jul, 2026 | blog

“Lipids and Health” Conference: Early Diagnosis, Multidisciplinary Care and Access to Treatment https://lald.org/wp-content/uploads/2026/07/Jornada-Lipidos-y-Salud.mp4   On June 30, the Faculty of Medicine of the University of Barcelona hosted the “Lipids and...
LAL-D: much more than a rare disease

LAL-D: much more than a rare disease

14 May, 2026 | blog

A new publication in Hepatology International provides important evidence about the role of lysosomal acid lipase (LAL) in liver disease progression. The study shows that lower LAL activity is associated with: 👉 Increased liver inflammation 👉 Greater fibrosis...